Jelinek, T.; Schwarz, T.F.; Reisinger, E.; Malfertheiner, P.; Versage, E.; Van Twuijver, E.; Hohenboken, M.
Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions. Vaccines 2024, 12, 481.
https://doi.org/10.3390/vaccines12050481
AMA Style
Jelinek T, Schwarz TF, Reisinger E, Malfertheiner P, Versage E, Van Twuijver E, Hohenboken M.
Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions. Vaccines. 2024; 12(5):481.
https://doi.org/10.3390/vaccines12050481
Chicago/Turabian Style
Jelinek, Tomas, Tino F. Schwarz, Emil Reisinger, Peter Malfertheiner, Eve Versage, Esther Van Twuijver, and Matthew Hohenboken.
2024. "Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions" Vaccines 12, no. 5: 481.
https://doi.org/10.3390/vaccines12050481
APA Style
Jelinek, T., Schwarz, T. F., Reisinger, E., Malfertheiner, P., Versage, E., Van Twuijver, E., & Hohenboken, M.
(2024). Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions. Vaccines, 12(5), 481.
https://doi.org/10.3390/vaccines12050481